高级检索
当前位置: 首页 > 详情页

Plasticity and Overlap of In Vitro-Induced Regulatory T-Cell Markers in Healthy Humans

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ CPCI(ISTP)

单位: [1]Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Heidelberg, Germany [2]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Minist Hlth,Inst Organ Transplantat,Minist Educ,Key Lab Organ Transplantat,Wuhan 430074,Peoples R China
出处:
ISSN:

摘要:
Induced regulatory T cells (iTreg) are a heterogeneous T-cell subset that is induced during an allo-response and down-regulates the immune response. iTreg are commonly characterized as CD4(+)CD25(high), CD4(+)CD25(high)FoxP3(+), CD4(+)CD25(high)CD127(-), or CD4(+)CD25(high)FoxP3(+)CD127(-) peripheral blood lymphocytes (PBL). In the present study, we investigated the overlap of these 4 phenotypically determined iTreg subsets in normal human individuals. PBL of 8 healthy individuals were incubated for 0 hours (Group 1) or for 16 hours in medium without (Group 2) or with phorbol 12-myristate 13-acetate (PMA)/Ionomycin (Group 3). Thereafter, proportions of PBL with Treg phenotypes were determined using 4-color flow-cytometry. All 4 Treg subsets increased strongly during polyclonal stimulation (P < .001). After stimulation, combining 2 iTreg markers, 24% of stimulated CD4(+) PBL were CD25(high)FoxP3(+), 18% CD25(high)CD127(-), and 61% FoxP3(+)CD127(-). Combining 3 iTreg markers, only 18% of the polyclonally stimulated CD4(+) PBL were CD25(high)FoxP3(+)CD127(-). Importantly, the proportion of FoxP3(+)CD127(-) PBL increased with the quantity of CD25 on stimulated CD4(+) PBL and was highest in CD25(high) PBL (P = .002), emphasizing the relevance of CD25(high) as iTreg marker. Different iTreg phenotypes should not be used interchangeably because they define different iTreg subsets that overlap only in part. CD25(high) is the most relevant iTreg marker. These conclusions should be considered when studies and experiments involving iTreg phenotypes are compared.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2012]版:
大类 | 4 区 医学
小类 | 4 区 免疫学 4 区 外科 4 区 移植
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 免疫学 4 区 外科 4 区 移植
JCR分区:
出版当年[2011]版:
Q3 SURGERY Q4 TRANSPLANTATION Q4 IMMUNOLOGY
最新[2023]版:
Q4 IMMUNOLOGY Q4 SURGERY Q4 TRANSPLANTATION

影响因子: 最新[2023版] 最新五年平均 出版当年[2011版] 出版当年五年平均 出版前一年[2010版] 出版后一年[2012版]

第一作者:
第一作者单位: [1]Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Heidelberg, Germany [2]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Minist Hlth,Inst Organ Transplantat,Minist Educ,Key Lab Organ Transplantat,Wuhan 430074,Peoples R China [*1]Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Neuenheimer Feld 305, Heidelberg, Germany
通讯作者:
通讯机构: [1]Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Heidelberg, Germany [2]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Minist Hlth,Inst Organ Transplantat,Minist Educ,Key Lab Organ Transplantat,Wuhan 430074,Peoples R China [*1]Heidelberg Univ, Inst Immunol, Dept Transplantat Immunol, Neuenheimer Feld 305, Heidelberg, Germany
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)